dc.contributor.author | Roshan, HR | |
dc.contributor.author | Azarm, A | |
dc.contributor.author | Mahmoudian, B | |
dc.contributor.author | Islamian, JP | |
dc.date.accessioned | 2018-08-26T05:43:47Z | |
dc.date.available | 2018-08-26T05:43:47Z | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/40775 | |
dc.description.abstract | Radioembolization (RE) with Yttrium-90 ((90)Y) microspheres is an effective treatment for unresectable liver tumors. The activity of the microspheres to be administered should be calculated based on the type of microspheres. Technetium-99m macroaggregated albumin ((99m)Tc-MAA) single photon emission computed tomography/computed tomography (SPECT/CT) is a reliable assessment before RE to ensure the safe delivery of microspheres into the target. (90)Y bremsstrahlung SPECT imaging as a posttherapeutic assessment approach enables the reliable determination of absorbed dose, which is indispensable for the verification of treatment efficacy. This article intends to provide a review of the methods of optimizing (90)Y bremsstrahlung SPECT imaging to improve the treatment efficacy of liver tumor RE using (90)Y microspheres. | |
dc.language.iso | English | |
dc.relation.ispartof | World journal of nuclear medicine | |
dc.title | Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres. | |
dc.type | article | |
dc.citation.volume | 14 | |
dc.citation.issue | 2 | |
dc.citation.spage | 75 | |
dc.citation.epage | 80 | |
dc.citation.index | Pubmed | |
dc.identifier.DOI | https://doi.org/10.4103/1450-1147.157120 | |